Fritextsökning
Artiklar per år
-
He saved lives with his theories – was ostracised and ended up in a mental hospital
Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with luck and timing.
-
"Unclear proposal from the EU Commission on how to solve the MDR challenges"
Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the availability of medical devices in the EU. Unfortunately, the fears have come true.
-
Svensk studie ger ökat hopp om nasalt covidvaccin
Höga nivåer av antikroppar mot sars-cov-2-viruset i näsans slemhinna ger skydd mot covid-19-smitta i minst åtta månader, enligt en svensk studie. Resultaten anses öka förhoppningarna om ett effektivt nasalt vaccin.
-
The new Astra Zeneca CEO: “An incredibly exciting phase”
Almost 27 years have passed since Per Alfredsson from Södertälje stepped into Astra Zeneca as a newly hired engineer. After countless different roles, including heading the production of the company’s Covid vaccine, he is now advancing to the absolute top.
-
”Otydligt förslag från EU-kommissionen om hur MDR-utmaningarna ska lösas”
Redan innan EU-förordningen om medicintekniska produkter (MDR) trädde i kraft fanns en oro hos medicinteknikföretag och läkare för att den skulle äventyra tillgången på medicintekniska produkter i EU. Farhågorna har dessvärre besannats.
-
Koppling mellan tatueringar och cancer undersöks av svenska forskare
Farhågor har länge funnits om att tatueringar kan öka risken för vissa typer av cancer. Nu undersöks det eventuella sambandet i ett forskningsprojekt i Lund.
-
Sweden is organising a large life science conference as part of the EU presidency
On 26-27 June, Sweden will host a European meeting on life science.
-
“Everyone is screaming for talent”
Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Horizons in Biologics & Bioprocessing conference on 15 December.